Conference Details - Agenda

View all Conferences

Continuing Education Information

Physicians: Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource designates this educational activity for a maximum of 16.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA category 1 CME credit for the PRA from organizations accredited by the ACCME.

Ninth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy

Sheraton New York Hotel & Towers
New York, NY
October 8-10, 2010

Friday, October 8, 2010

7:30 am Registration and Continental Breakfast
8:00 am Welcome and Introductions
Breast Cancer Molecular Pathology
8:05 am Presession Survey
8:10 am Discoveries From Breast Cancer Sequencing
Elaine Mardis
8:30 am Pathways Driving Aggressive Breast Cancer
Philippe Bedard
8:50 am Tumor Size: Biology and Prognosis
William Foulkes
9:10 am Targeting Metastasis
Andrea Richardson
9:30 am Postsession Survey
9:35 am Panel Discussion
10:00 am Break
Indolent ER-Positive Breast Cancer
10:20 am Presession Survey
10:25 am Biology of Luminal Breast Cancer
William F. Symmans
10:45 am Predictors of Favorable Biology
Stephen Chia
  Chemotherapy Should Be Avoided in Luminal Breast Cancer
11:05 am Point
Kathy Albain
11:25 am Counterpoint
Charles E. Geyer, Jr
11:45 am Panel Discussion
12:10 pm Lunch
Indolent ER-Positive Breast Cancer (continued)
  Optimizing Endocrine Therapy
1:10 pm Premenopausal
Lori J. Goldstein
1:30 pm Postmenopausal
Edward Romond
1:50 pm Preoperative Endocrine Therapy: Emerging Insights
Steven Come
2:10 pm Postsession Survey
2:15 pm Panel Discussion
2:40 pm Break
Aggressive ER-Positive Breast Cancer
3:00 pm Presession Survey
3:05 pm Escape Mechanisms From Endocrine Therapy
C. Kent Osborne
3:25 pm Optimizing Adjuvant Chemotherapy for Luminal Breast Cancer
Jo Anne Zujewski
3:45 pm Novel Cytotoxic Agents for Aggressive Breast Cancer
Joyce O'Shaughnessy
4:05 pm Adjuvant Breast Cancer Therapy: Hypotheses for the Future
Clifford Hudis
4:25 pm Postsession Survey
4:30 pm Panel Discussion
4:55 pm Adjourn

Educational Grants

An educational grant for this activity was provided by:


  1. Genentech
  2. Novartis Oncology
  3. sanofi-aventis U.S.